nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM1—trigeminal nerve—intracranial aneurysm	0.13	0.153	CbGeAlD
Phenoxybenzamine—CALM1—cranial nerve—intracranial aneurysm	0.0927	0.109	CbGeAlD
Phenoxybenzamine—CALM2—pons—intracranial aneurysm	0.092	0.108	CbGeAlD
Phenoxybenzamine—CALM1—pons—intracranial aneurysm	0.0916	0.108	CbGeAlD
Phenoxybenzamine—CALM2—artery—intracranial aneurysm	0.0481	0.0567	CbGeAlD
Phenoxybenzamine—CALM1—artery—intracranial aneurysm	0.0479	0.0564	CbGeAlD
Phenoxybenzamine—CALM2—brainstem—intracranial aneurysm	0.0205	0.0241	CbGeAlD
Phenoxybenzamine—CALM1—brainstem—intracranial aneurysm	0.0204	0.024	CbGeAlD
Phenoxybenzamine—ADRA1A—brainstem—intracranial aneurysm	0.0192	0.0226	CbGeAlD
Phenoxybenzamine—CALM3—medulla oblongata—intracranial aneurysm	0.0182	0.0214	CbGeAlD
Phenoxybenzamine—CALM3—midbrain—intracranial aneurysm	0.0166	0.0196	CbGeAlD
Phenoxybenzamine—CALM2—medulla oblongata—intracranial aneurysm	0.0143	0.0168	CbGeAlD
Phenoxybenzamine—CALM1—medulla oblongata—intracranial aneurysm	0.0142	0.0167	CbGeAlD
Phenoxybenzamine—ADRA1B—brain—intracranial aneurysm	0.0137	0.0161	CbGeAlD
Phenoxybenzamine—ADRA1D—brain—intracranial aneurysm	0.0134	0.0158	CbGeAlD
Phenoxybenzamine—CALM2—midbrain—intracranial aneurysm	0.0131	0.0154	CbGeAlD
Phenoxybenzamine—CALM1—midbrain—intracranial aneurysm	0.013	0.0153	CbGeAlD
Phenoxybenzamine—CALM3—cerebellum—intracranial aneurysm	0.0129	0.0151	CbGeAlD
Phenoxybenzamine—ADRA2C—medulla oblongata—intracranial aneurysm	0.0128	0.015	CbGeAlD
Phenoxybenzamine—ADRA2C—midbrain—intracranial aneurysm	0.0117	0.0137	CbGeAlD
Phenoxybenzamine—CALM3—brain—intracranial aneurysm	0.0104	0.0123	CbGeAlD
Phenoxybenzamine—ADRA2A—medulla oblongata—intracranial aneurysm	0.0102	0.012	CbGeAlD
Phenoxybenzamine—SLC22A1—brain—intracranial aneurysm	0.0101	0.0119	CbGeAlD
Phenoxybenzamine—CALM2—cerebellum—intracranial aneurysm	0.0101	0.0119	CbGeAlD
Phenoxybenzamine—CALM1—cerebellum—intracranial aneurysm	0.0101	0.0118	CbGeAlD
Phenoxybenzamine—SLC22A3—brain—intracranial aneurysm	0.00966	0.0114	CbGeAlD
Phenoxybenzamine—ADRA1A—cerebellum—intracranial aneurysm	0.00947	0.0112	CbGeAlD
Phenoxybenzamine—ADRA2A—midbrain—intracranial aneurysm	0.00931	0.011	CbGeAlD
Phenoxybenzamine—ADRA2C—cerebellum—intracranial aneurysm	0.00903	0.0106	CbGeAlD
Phenoxybenzamine—CALM2—brain—intracranial aneurysm	0.0082	0.00966	CbGeAlD
Phenoxybenzamine—CALM1—brain—intracranial aneurysm	0.00817	0.00962	CbGeAlD
Phenoxybenzamine—ADRA1A—brain—intracranial aneurysm	0.00769	0.00906	CbGeAlD
Phenoxybenzamine—ADRA2C—brain—intracranial aneurysm	0.00733	0.00864	CbGeAlD
Phenoxybenzamine—ADRA2A—cerebellum—intracranial aneurysm	0.0072	0.00848	CbGeAlD
Phenoxybenzamine—ADRA2A—brain—intracranial aneurysm	0.00585	0.00689	CbGeAlD
Phenoxybenzamine—CALM1—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00137	0.00905	CbGpPWpGaD
Phenoxybenzamine—CALM2—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00137	0.00905	CbGpPWpGaD
Phenoxybenzamine—CALM2—Endothelin Pathways—NOS3—intracranial aneurysm	0.00131	0.00869	CbGpPWpGaD
Phenoxybenzamine—CALM1—Endothelin Pathways—NOS3—intracranial aneurysm	0.00131	0.00869	CbGpPWpGaD
Phenoxybenzamine—CALM3—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00128	0.00845	CbGpPWpGaD
Phenoxybenzamine—CALM2—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00124	0.00818	CbGpPWpGaD
Phenoxybenzamine—CALM1—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00124	0.00818	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.00123	0.00817	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by VEGF—NCF1—intracranial aneurysm	0.00121	0.00798	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by VEGF—NCF1—intracranial aneurysm	0.00117	0.00772	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by VEGF—NCF1—intracranial aneurysm	0.00117	0.00772	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—LPA receptor mediated events—MMP2—intracranial aneurysm	0.00113	0.0075	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.0011	0.00731	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.00102	0.00678	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—SLC25A16—intracranial aneurysm	0.000991	0.00656	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000954	0.00632	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00095	0.00629	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000916	0.00606	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.00091	0.00602	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000887	0.00587	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—STARD13—intracranial aneurysm	0.000865	0.00573	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000861	0.0057	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—LPA receptor mediated events—MMP9—intracranial aneurysm	0.000851	0.00563	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00085	0.00563	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000817	0.00541	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000814	0.00539	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000805	0.00533	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000792	0.00524	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—STARD13—intracranial aneurysm	0.000781	0.00517	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—STARD13—intracranial aneurysm	0.000771	0.0051	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000761	0.00504	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000738	0.00489	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000736	0.00487	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000736	0.00487	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—STARD13—intracranial aneurysm	0.00073	0.00483	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000729	0.00482	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000721	0.00477	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—STARD13—intracranial aneurysm	0.000718	0.00475	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000703	0.00466	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000689	0.00456	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000678	0.00449	CbGpPWpGaD
Phenoxybenzamine—CALM3—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000658	0.00435	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—ASAH1—intracranial aneurysm	0.000657	0.00435	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000654	0.00433	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STARD13—intracranial aneurysm	0.000638	0.00422	CbGpPWpGaD
Phenoxybenzamine—CALM1—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000636	0.00421	CbGpPWpGaD
Phenoxybenzamine—CALM2—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000636	0.00421	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000622	0.00412	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—SLC25A16—intracranial aneurysm	0.000622	0.00412	CbGpPWpGaD
Phenoxybenzamine—CALM1—Endochondral Ossification—MMP9—intracranial aneurysm	0.00062	0.0041	CbGpPWpGaD
Phenoxybenzamine—CALM2—Endochondral Ossification—MMP9—intracranial aneurysm	0.00062	0.0041	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—SLC25A16—intracranial aneurysm	0.000605	0.004	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000603	0.00399	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STARD13—intracranial aneurysm	0.000593	0.00392	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—SLC25A16—intracranial aneurysm	0.00058	0.00384	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000562	0.00372	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00056	0.00371	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000555	0.00367	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STARD13—intracranial aneurysm	0.000541	0.00358	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—SLC25A16—intracranial aneurysm	0.000535	0.00354	CbGpPWpGaD
Phenoxybenzamine—CALM3—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00053	0.00351	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000525	0.00347	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STARD13—intracranial aneurysm	0.000523	0.00346	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STARD13—intracranial aneurysm	0.000523	0.00346	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—SLC25A16—intracranial aneurysm	0.000518	0.00343	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—SLC25A16—intracranial aneurysm	0.000518	0.00343	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000517	0.00342	CbGpPWpGaD
Phenoxybenzamine—CALM1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000512	0.00339	CbGpPWpGaD
Phenoxybenzamine—CALM2—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000512	0.00339	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by VEGF—NOS3—intracranial aneurysm	0.0005	0.00331	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—SLC25A16—intracranial aneurysm	0.000491	0.00325	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—TIMP1—intracranial aneurysm	0.00049	0.00324	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by VEGF—NOS3—intracranial aneurysm	0.000484	0.0032	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by VEGF—NOS3—intracranial aneurysm	0.000484	0.0032	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000459	0.00304	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—TIMP1—intracranial aneurysm	0.000457	0.00303	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—SLC25A16—intracranial aneurysm	0.000448	0.00297	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—CTSS—intracranial aneurysm	0.000438	0.0029	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—SLC25A16—intracranial aneurysm	0.000434	0.00287	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—SLC25A16—intracranial aneurysm	0.000434	0.00287	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000426	0.00282	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CTSS—intracranial aneurysm	0.000423	0.0028	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CTSS—intracranial aneurysm	0.000423	0.0028	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CTSS—intracranial aneurysm	0.00042	0.00278	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—ASAH1—intracranial aneurysm	0.000412	0.00273	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CTSS—intracranial aneurysm	0.000407	0.00269	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CTSS—intracranial aneurysm	0.000407	0.00269	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000403	0.00267	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—CTSK—intracranial aneurysm	0.000403	0.00267	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—ASAH1—intracranial aneurysm	0.000401	0.00265	CbGpPWpGaD
Phenoxybenzamine—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.000394	0.00261	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CTSK—intracranial aneurysm	0.00039	0.00258	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CTSK—intracranial aneurysm	0.00039	0.00258	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CTSK—intracranial aneurysm	0.000387	0.00256	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—ASAH1—intracranial aneurysm	0.000384	0.00254	CbGpPWpGaD
Phenoxybenzamine—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.000381	0.00252	CbGpPWpGaD
Phenoxybenzamine—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.000381	0.00252	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CTSK—intracranial aneurysm	0.000374	0.00248	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CTSK—intracranial aneurysm	0.000374	0.00248	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TIMP1—intracranial aneurysm	0.000372	0.00246	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000364	0.00241	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000359	0.00238	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000352	0.00233	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00034	0.00225	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TIMP1—intracranial aneurysm	0.000339	0.00224	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000334	0.00221	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—CTSB—intracranial aneurysm	0.000333	0.00221	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TIMP1—intracranial aneurysm	0.000328	0.00217	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TIMP1—intracranial aneurysm	0.000328	0.00217	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ASAH1—intracranial aneurysm	0.000325	0.00215	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CTSB—intracranial aneurysm	0.000322	0.00213	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CTSB—intracranial aneurysm	0.000322	0.00213	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CTSB—intracranial aneurysm	0.00032	0.00212	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000319	0.00211	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—NCF1—intracranial aneurysm	0.000318	0.00211	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000318	0.0021	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000314	0.00208	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CTSB—intracranial aneurysm	0.00031	0.00205	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CTSB—intracranial aneurysm	0.00031	0.00205	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—NCF1—intracranial aneurysm	0.000308	0.00204	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—NCF1—intracranial aneurysm	0.000308	0.00204	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—CCL2—intracranial aneurysm	0.000307	0.00203	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000297	0.00197	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ASAH1—intracranial aneurysm	0.000297	0.00197	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000297	0.00196	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000292	0.00193	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000288	0.00191	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ASAH1—intracranial aneurysm	0.000287	0.0019	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ASAH1—intracranial aneurysm	0.000287	0.0019	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000285	0.00188	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—CCL2—intracranial aneurysm	0.000277	0.00183	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000276	0.00183	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—CCL2—intracranial aneurysm	0.000273	0.00181	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000269	0.00178	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000265	0.00176	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000259	0.00172	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—CCL2—intracranial aneurysm	0.000259	0.00171	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CTSS—intracranial aneurysm	0.000255	0.00169	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—CCL2—intracranial aneurysm	0.000255	0.00169	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CTSS—intracranial aneurysm	0.000247	0.00163	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CTSS—intracranial aneurysm	0.000247	0.00163	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000241	0.0016	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000236	0.00156	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CTSK—intracranial aneurysm	0.000235	0.00155	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CTSK—intracranial aneurysm	0.000227	0.0015	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CTSK—intracranial aneurysm	0.000227	0.0015	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—CCL2—intracranial aneurysm	0.000226	0.0015	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—NOS3—intracranial aneurysm	0.000221	0.00146	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000219	0.00145	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—AGER—intracranial aneurysm	0.000215	0.00142	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—CCL2—intracranial aneurysm	0.00021	0.00139	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000209	0.00139	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—AGER—intracranial aneurysm	0.000208	0.00138	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—AGER—intracranial aneurysm	0.000208	0.00138	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—NOS3—intracranial aneurysm	0.000206	0.00136	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CST3—intracranial aneurysm	0.000205	0.00136	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NCF1—intracranial aneurysm	0.0002	0.00132	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—EDNRA—intracranial aneurysm	0.0002	0.00132	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CST3—intracranial aneurysm	0.000198	0.00131	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CST3—intracranial aneurysm	0.000198	0.00131	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CTSB—intracranial aneurysm	0.000194	0.00129	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—NCF1—intracranial aneurysm	0.000193	0.00128	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000193	0.00128	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000193	0.00128	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EDNRA—intracranial aneurysm	0.000189	0.00125	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CTSB—intracranial aneurysm	0.000188	0.00124	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CTSB—intracranial aneurysm	0.000188	0.00124	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—NCF1—intracranial aneurysm	0.000187	0.00124	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—NCF1—intracranial aneurysm	0.000187	0.00124	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NCF1—intracranial aneurysm	0.00018	0.00119	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NCF1—intracranial aneurysm	0.000178	0.00118	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NCF1—intracranial aneurysm	0.000178	0.00118	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NCF1—intracranial aneurysm	0.000173	0.00114	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NCF1—intracranial aneurysm	0.000173	0.00114	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EDNRA—intracranial aneurysm	0.00017	0.00113	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NCF1—intracranial aneurysm	0.000169	0.00112	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000168	0.00111	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—NOS3—intracranial aneurysm	0.000167	0.00111	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NCF1—intracranial aneurysm	0.000166	0.0011	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EDNRA—intracranial aneurysm	0.000159	0.00105	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—CCL2—intracranial aneurysm	0.000157	0.00104	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EDNRA—intracranial aneurysm	0.000157	0.00104	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—NOS3—intracranial aneurysm	0.000153	0.00101	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—NOS3—intracranial aneurysm	0.000148	0.000978	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—NOS3—intracranial aneurysm	0.000148	0.000978	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NCF1—intracranial aneurysm	0.000147	0.000975	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—CCL2—intracranial aneurysm	0.000142	0.000941	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CCL2—intracranial aneurysm	0.00014	0.000929	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EDNRA—intracranial aneurysm	0.000139	0.000921	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000139	0.000918	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—NOS3—intracranial aneurysm	0.000137	0.000907	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NCF1—intracranial aneurysm	0.000137	0.000906	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CCL2—intracranial aneurysm	0.000133	0.000879	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CCL2—intracranial aneurysm	0.000131	0.000865	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EDNRA—intracranial aneurysm	0.000129	0.000856	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AGER—intracranial aneurysm	0.000125	0.00083	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NCF1—intracranial aneurysm	0.000125	0.000827	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AGER—intracranial aneurysm	0.000121	0.000803	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AGER—intracranial aneurysm	0.000121	0.000803	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NCF1—intracranial aneurysm	0.000121	0.0008	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NCF1—intracranial aneurysm	0.000121	0.0008	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000118	0.000781	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CCL2—intracranial aneurysm	0.000116	0.000768	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000114	0.000755	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000114	0.000755	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CCL2—intracranial aneurysm	0.000108	0.000714	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CCL2—intracranial aneurysm	9.84e-05	0.000651	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CCL2—intracranial aneurysm	9.52e-05	0.00063	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CCL2—intracranial aneurysm	9.52e-05	0.00063	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CCL2—intracranial aneurysm	9.3e-05	0.000616	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—NOS3—intracranial aneurysm	8.59e-05	0.000569	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCL2—intracranial aneurysm	8.4e-05	0.000556	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—NOS3—intracranial aneurysm	8.36e-05	0.000553	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCL2—intracranial aneurysm	8.29e-05	0.000549	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NOS3—intracranial aneurysm	8.29e-05	0.000549	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—NOS3—intracranial aneurysm	8.01e-05	0.00053	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCL2—intracranial aneurysm	7.84e-05	0.000519	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCL2—intracranial aneurysm	7.72e-05	0.000511	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NOS3—intracranial aneurysm	7.48e-05	0.000495	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOS3—intracranial aneurysm	7.4e-05	0.00049	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NOS3—intracranial aneurysm	7.39e-05	0.000489	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOS3—intracranial aneurysm	7.16e-05	0.000474	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOS3—intracranial aneurysm	7.16e-05	0.000474	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NOS3—intracranial aneurysm	6.99e-05	0.000463	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NOS3—intracranial aneurysm	6.88e-05	0.000455	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCL2—intracranial aneurysm	6.86e-05	0.000454	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—NOS3—intracranial aneurysm	6.79e-05	0.000449	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP9—intracranial aneurysm	6.65e-05	0.00044	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL2—intracranial aneurysm	6.37e-05	0.000422	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—NOS3—intracranial aneurysm	6.2e-05	0.00041	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NOS3—intracranial aneurysm	6.11e-05	0.000404	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP9—intracranial aneurysm	6e-05	0.000397	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—NOS3—intracranial aneurysm	5.99e-05	0.000397	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—NOS3—intracranial aneurysm	5.99e-05	0.000397	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP9—intracranial aneurysm	5.93e-05	0.000392	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL2—intracranial aneurysm	5.81e-05	0.000385	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NOS3—intracranial aneurysm	5.68e-05	0.000376	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL2—intracranial aneurysm	5.62e-05	0.000372	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL2—intracranial aneurysm	5.62e-05	0.000372	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP9—intracranial aneurysm	5.61e-05	0.000371	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP9—intracranial aneurysm	5.52e-05	0.000365	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NOS3—intracranial aneurysm	5.18e-05	0.000343	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NOS3—intracranial aneurysm	5.01e-05	0.000332	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NOS3—intracranial aneurysm	5.01e-05	0.000332	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—intracranial aneurysm	4.9e-05	0.000325	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—intracranial aneurysm	4.55e-05	0.000302	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—intracranial aneurysm	4.16e-05	0.000275	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—intracranial aneurysm	4.02e-05	0.000266	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—intracranial aneurysm	4.02e-05	0.000266	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NOS3—intracranial aneurysm	2.89e-05	0.000191	CbGpPWpGaD
